|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| A61K 38/36 | (2013.01) | ||
| A61K 38/37 | (2006.01) | ||
| A61P 7/04 | (2018.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61K 38/37 | (2013.01) |
| (11) | Number of the document | 3648788 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18746458.1 |
| Date of filing the European patent application | 2018-07-09 | |
| (97) | Date of publication of the European application | 2020-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2024-05-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/041320 |
| Date | 2018-07-09 |
| (87) | Number | WO 2019/010497 |
| Date | 2019-01-10 |
| (30) | Number | Date | Country code |
| 201762530027 P | 2017-07-07 | US |
| (72) |
CHAPMAN, Miranda , US
EWENSTEIN, Bruce , US
PLODER, Bettina , AT
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | TREATMENT OF GASTROINTESTINAL BLEEDING IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |
| TREATMENT OF GASTROINTESTINAL BLEEDING IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |